Scolaris Content Display Scolaris Content Display

Embolización para la malformación arteriovenosa pulmonar

Contraer todo Desplegar todo

Referencias

Referencias de los estudios excluidos de esta revisión

Ir a:

Dutton 1995 {published data only}

Dutton JA, Jackson JE, Hughes JM, Whyte MK, Peters AM, Ussov W, et al. Pulmonary arteriovenous malformations: results of treatment with coil embolization in 53 patients. American Journal of Roentgenology 1995;165(5):1119‐25. CENTRAL

Gupta 2002 {published data only}

Gupta P, Mordin C, Curtis J, Hughes JM, Shovlin CL, Jackson JE. Pulmonary arteriovenous malformations: effect of embolization on right‐to‐left shunt, hypoxemia, and exercise tolerance in 66 patients. American Journal of Roentgenology 2002;179(2):347‐55. CENTRAL

Haitjema 1995 {published data only}

Haitjema TJ, Overtoom TT, Westermann CJ, Lammers JW. Embolisation of pulmonary arteriovenous malformations: results and follow up in 32 patients. Thorax 1995;50(7):719‐23. CENTRAL

Lacombe 2009 {published data only}

Lacombe P, Lagrange C, Beauchet A, El Hajjam M, Chinet T, Pelage JP. Diffuse pulmonary arteriovenous malformations in hereditary hemorrhagic telangiectasia: long‐term results of embolization according to the extent of lung involvement. Chest 2009;135(4):1031‐7. CENTRAL

Liu 2010 {published data only}

Liu FY, Wang MQ, Fan QS, Duan F, Wang ZJ, Song P. Endovascular embolization of pulmonary arteriovenous malformations. Chinese Medical Journal 2010;123(1):23‐8. CENTRAL

Pollak 1994 {published data only}

Pollak JS, Egglin TK, Rosenblatt MM, Dickey KW, White RI. Clinical results of transvenous systemic embolotherapy with a neuroradiologic detachable balloon. Radiology 1994;191(2):477‐82. CENTRAL

Pollak 2006 {published data only}

Pollak JS, Saluja S, Thabet A, Henderson KJ, Denbow N, White RI. Clinical and anatomic outcomes after embolotherapy of pulmonary arteriovenous malformations. Journal of Vascular and Interventional Radiology 2006;17(1):35‐45. CENTRAL

Shovlin 2008a {published data only}

Shovlin CL, Jackson JE, Bamford KB, Jenkins IH, Benjamin AR, Ramadan H, et al. Primary determinants of ischaemic stroke/brain abscess risks are independent of severity of pulmonary arteriovenous malformations in hereditary haemorrhagic telangiectasia. Thorax 2008;63(3):259‐66. CENTRAL

Shovlin 2008b {published data only}

Shovlin CL, Tighe HC, Davies RJ, Gibbs JS, Jackson JE. Embolisation of pulmonary arteriovenous malformations: no consistent effect on pulmonary artery pressure. European Respiratory Journal 2008;32(1):162‐9. CENTRAL

Referencias de los estudios en curso

Ir a:

NCT01856842 {unpublished data only}

NCT01856842. Reperfusion of pulmonary arteriovenous malformations after embolotherapy. A randomized trial of Interlock™ Fibered IDC™ Occlusion System vs. Nester Coils. https://clinicaltrials.gov/ct2/show/NCT01856842 (accessed 03 December 2014). CENTRAL

Abdalla 2006

Abdalla SA, Letarte M. Hereditary haemorrhagic telangiectasia: current views on genetics and mechanisms of disease. Journal of Medical Genetics 2006;43(2):97‐110.

Bayrak‐Toydemir 2004

Bayrak‐Toydemir P, Mao R, Lewin S, McDonald J. Hereditary hemorrhagic telangiectasia: an overview of diagnosis and management in the molecular era for clinicians. Genetics in Medicine 2004;6(4):175‐91.

Borrero 2006

Borrero CG, Zajko AB. Pulmonary arteriovenous malformations: clinical Features, diagnosis, and treatment. Journal of Radiology Nursing 2006;25(2):33‐7.

Brillet 2007

Brillet PY, Dumont P, Bouaziz N, Duhamel A, Laurent F, Remy J, et al. Pulmonary arteriovenous malformation treated with embolotherapy: systemic collateral supply at multidetector CT angiography after 2‐20‐year follow‐up. Radiology 2007;242(1):267‐76.

Cil 2008

Cil B, Peynircioğlu B, Canyiğit M, Geyik S, Ciftçi T. Peripheral vascular applications of the Amplatzer vascular plug. Diagnostic and Interventional Radiology 2008;14(1):35‐9.

Cottin 2004

Cottin V, Plauchu H, Bayle JY, Barthelet M, Revel D, Cordier JF. Pulmonary arteriovenous malformations in patients with hereditary hemorrhagic telangiectasia. American Journal of Respiratory Criticial Care Medicine 2004;169(9):994‐1000.

Curie 2007

Curie A, Lesca G, Cottin V, Edery P, Bellon G, Faughnan ME, et al. Long‐term follow‐up in 12 children with pulmonary arteriovenous malformations: confirmation of hereditary hemorrhagic telangiectasia in all cases. Journal of Pediatrics 2007;151(3):299‐306.

Dakeishi 2002

Dakeishi M, Shioya T, Wada Y, Shindo T, Otaka K, Manabe M, Nozaki J, Inoue S, Koizumi A. Genetic epidemiology of hereditary hemorrhagic telangiectasia in a local community in the northern part of Japan. Human Mutation 2002;19(2):140–8.

Faughnan 2000

Faughnan ME, Lui YW, Wirth JA, Pugash RA, Redelmeier DA, Hyland RH, et al. Diffuse pulmonary arteriovenous malformations: characteristics and prognosis. Chest 2000;117(1):31‐8.

Faughnan 2004

Faughnan ME, Thabet A, Mei‐Zahav M, Colombo M, Maclusky I, Hyland RH, et al. Pulmonary arteriovenous malformations in children: Outcomes of transcatheter embolotherapy. Journal of Pediatrics 2004;145(6):826‐31.

Ferro 2007

Ferro C, Rossi UG, Bovio G, Seitun S, Rossi GA. Percutaneous transcatheter embolization of a large pulmonary arteriovenous fistula with an Amplatzer vascular plug. Cardiovascular and Interventional Radiology 2007;30(2):328‐31.

Gallione 2004

Gallione CJ, Repetto GM, Legius E, Rustgi AK, Schelley SL, Tejpar S, Mitchell G, Drouin E, Westermann CJ, Marchuk D. A combined syndrome of juvenile polyposis and hereditary haemorrhagic telangiectasia associated with mutations in MADH4 (SMAD4). Lancet 2004;363(9412):852‐9.

Govani 2009

Govani FS, Shovlin CL. Hereditary haemorrhagic telangiectasia: a clinical and scientific review. European Journal of Human Genetics 2009;17(7):860‐71.

Hannan 1989

Hannan EL, O'Donnell JF, Kilburn H, Bernard HR, Yazici A. Investigation of the relationship between volume and mortality for surgical procedures performed in New York State hospitals. JAMA 1989;262(4):503‐10.

Hayashi2012

Hayashi S1, Baba Y, Senokuchi T, Nakajo M. Efficacy of venous sac embolization for pulmonary arteriovenous malformations: comparison with feeding artery embolization. Journal of Vascular and Interventional Radiology 2012;23(12):1566‐77.

Higgins 2011

Higgins JPT, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.handbook.cochrane.org.

Khurshid 2002

Khurshid I, Downie GH. Pulmonary arteriovenous malformation. Postgraduate Medical Journal 2002;78(918):191‐7.

Kjeldsen 1999

Kjeldsen AD, Vase P, Green A. Hereditary haemorrhagic telangiectasia: a population‐based study of prevalence and mortality in Danish patients. Journal of Internal Medicine 1999;245(1):31‐9.

Lee 1997

Lee DW, White RI, Egglin TK, Pollak JS, Fayad PB, Wirth JA, et al. Embolotherapy of large pulmonary arteriovenous malformations: long‐term results. Annals of Thoracic Surgery 1997;64(4):930‐40.

Letteboer 2006

Letteboer TG, Mager JJ, Snijder RJ, Koeleman BP, Lindhout D, Ploos van Amstel JK, et al. Genotype‐phenotype relationship in hereditary haemorrhagic telangiectasia. Journal of Medical Genetetics 2006;43(4):371‐7.

Mager 2004

Mager JJ, Overtoom TT, Blauw H, Lammers JW, Westermann CJ. Embolotherapy of pulmonary arteriovenous malformations: long‐term results in 112 patients. Journal of Vascular and Interventional Radiology 2004;15(5):451‐6.

Makimoto 2014

Makimoto S, Hiraki T, Gobara H, Fujiwara H, Iguchi T, Matsui Y, Mimura H, Kanazawa S. Association between reperfusion and shrinkage percentage of the aneurysmal sac after embolization of pulmonary arteriovenousmalformation: evaluation based on contrast‐enhanced thin‐section CT images. Japanese Journal of Radiology 2014;32(5):266‐73.

Mathis 2012

Mathis S, Dupuis‐Girod S, Plauchu H, Giroud M, Barroso B, Ly KH, et al. Cerebral abscesses in hereditary haemorrhagic telangiectasia: a clinical and microbiological evaluation. Clinical Neurology and Neurosurgery 2012;114(3):235‐40.

Pierucci 2008

Pierucci P, Murphy J, Henderson KJ, Chyun DA, White RI. New definition and natural history of patients with diffuse pulmonary arteriovenous malformations: twenty‐seven‐year experience. Chest 2008;133(3):653‐61.

Post 2006

Post MC, Thijs V, Schonewille WJ, Budts W, Snijder RJ, Plokker HW, et al. Embolization of pulmonary arteriovenous malformations and decrease in prevalence of migraine. Neurology 2006;66(2):202‐5.

Prasad 2004

Prasad V, Chan RP, Faughnan ME. Embolotherapy of pulmonary arteriovenous malformations: efficacy of platinum versus stainless steel coils. Journal of Vascular and Interventional Radiology 2004;15(2 Pt 1):153‐60.

Remy 1992

Remy J, Remy‐Jardin M, Wattinne L, Deffontaines C. Pulmonary arteriovenous malformations: evaluation with CT of the chest before and after treatment. Radiology 1992;182(3):809‐16.

Remy 1994

Remy J, Remy‐Jardin M, Giraud F, Wattinne L. Angioarchitectureof pulmonary arteriovenous malformations:clinical utility of 3D helical CT. Radiology 1994;191(3):657–64.

Remy‐Jardin 2006

Remy‐Jardin M, Dumont P, Brillet PY, Dupuis P, Duhamel A, Remy J. Pulmonary arteriovenous malformations treated with embolotherapy: helical CT evaluation of long‐term effectiveness after 2‐21‐year follow‐up. Radiology 2006;239(2):576‐85.

Sabbà 2006

Sabbà C, Pasculli G, Suppressa P, D'Ovidio F, Lenato GM, Resta F, et al. Life expectancy in patients with hereditary haemorrhagic telangiectasia. QJM: An International Journal of Medicine 2006;99(5):327‐34.

Sagara 1998

Sagara K, Miyazono N, Inoue H, Ueno K, Nishida H, Nakajo M. Recanalization after coil embolotherapy of pulmonary arteriovenous malformations: study of long‐term outcome and mechanism for recanalization. American Journal of Roentgenology 1998;170(3):727‐30.

Saluja 1999

Saluja S, Sitko I, Lee DW, Pollak J, White RI. Embolotherapy of pulmonary arteriovenous malformations with detachable balloons: long‐term durability and efficacy. Journal of Vascular and Interventional Radiology 1999;10(7):883‐9.

Shovlin 2000

Shovlin CL, Guttmacher AE, Buscarini E, Faughnan ME, Hyland RH, Westermann CJ, et al. Diagnostic criteria for hereditary hemorrhagic telangiectasia (Rendu‐Osler‐Weber syndrome). American Journal of Medical Genetics 2000;91(1):66‐7.

Shovlin 2008c

Shovlin CL, Sodhi V, McCarthy A, Lasjaunias P, Jackson JE, Sheppard MN. Estimates of maternal risks of pregnancy for women with hereditary haemorrhagic telangiectasia (Osler‐Weber‐Rendu syndrome): suggested approach for obstetric services. BJOG: An International Journal of Obstetrics and Gynaecology 2008;115(8):1108‐15.

Shovlin 2010

Shovlin CL, Jackson JE. Pulmonary arteriovenous malformations and other pulmonary vascular abnormalities. In: Mason , Broaddus , Martin , Schraufnagel , Murray , Nadel editor(s). Murray and Nadel's Textbook of Respiratory Medicine, 5th Edition. Pennsylvania: Elsevier‐Saunders, 2010.

Shovlin 2017

Shovlin CL, Condliffe R, Donaldson JW, Kiely DG, Wort SJ, British Thoracic Society. British Thoracic Society clinical statement on pulmonary arteriovenous malformations. Thorax 2017;72(12):1154‐63.

Swanson 1999

Swanson KL, Prakash UB, Stanson AW. Pulmonary arteriovenous fistulas: Mayo Clinic experience, 1982‐1997. Mayo Clinic Proceedings 1999;74(7):671‐80.

White 1983

White RI, Mitchell SE, Barth KH, Kaufman SL, Kadir S, Chang R, et al. Angioarchitecture of pulmonary arteriovenous malformations: an important consideration before embolotherapy. American Journal of Roentgenology 1983;140(4):681‐6.

White 1988

White RI, Lynch‐Nyhan A, Terry P, Buescher PC, Farmlett EJ, Charnas L, et al. Pulmonary arteriovenous malformations: techniques and long‐term outcome of embolotherapy. Radiology 1988;169(3):663‐9.

White 2007

White RI. Pulmonary Arteriovenous Malformations: How Do I Embolize?. Techniques in Vascular and Interventional Radiology 2007;10(4):283‐90.

Referencias de otras versiones publicadas de esta revisión

Ir a:

Hsu 2010

Hsu CCT, Kwan GNC, Thompson SA, van Driel ML. Embolisation therapy for pulmonary arteriovenous malformations. Cochrane Database of Systematic Reviews 2010, Issue 5. [DOI: 10.1002/14651858.CD008017.pub2]

Hsu 2012

Hsu CC, Kwan GN, Thompson SA, van Driel ML. Embolisation therapy for pulmonary arteriovenous malformations. Cochrane Database of Systematic Reviews 2012, Issue 8. [DOI: 10.1002/14651858.CD008017.pub3]

Hsu 2015

Hsu CCT, Kwan GNC, Thompson SA, Evans‐Barns H, van Driel ML. Embolisation for pulmonary arteriovenous malformation. Cochrane Database of Systematic Reviews 2015, Issue 1. [DOI: 10.1002/14651858.CD008017.pub4]

Characteristics of studies

Characteristics of excluded studies [ordered by study ID]

Ir a:

Study

Reason for exclusion

Dutton 1995

Prospective case series of 53 participants with PAVMs treated with coil embolisation.

Gupta 2002

Prospective case series of 66 consecutive individuals, 225 PAVMs were occluded by coil embolisation.

Haitjema 1995

Prospective case series of 32 individuals, 92 PAVMs were treated by coil embolisation.

Lacombe 2009

Prospective case series of 39 individuals previously identified to have bilateral PAVMs. 681 PAVMs were occluded by embolisation. 238 PAVMs were treated using the peripheral blood flow redistribution technique.

Liu 2010

Prospective study of 23 patients with symptomatic PAVMs underwent endovascular embolization; 7 cases were associated with HHT. During the embolization, microcoils were applied in 6 cases and standard steel coils were used in 17 cases.

Pollak 1994

Prospective study of 35 individuals, 96 PAVMs, underwent embolisation with detachable silicone balloon, coil or combination.

Pollak 2006

Prospective study of 155 individuals, 415 PAVMs underwent embolisation with balloon, coil or combination of both.

Shovlin 2008a

Prospective study of 323 consecutive individuals with PAVMs (n = 219) and/or HHT (n = 305) was performed. Anderson–Gill models assessed constant and time dependent potential predictive variables for stroke/abscess, and rate reduction by PAVMs embolisation.

Shovlin 2008b

Prospective study of 143 individuals, 4 individuals were excluded from the study due to severe pulmonary hypertension, underwent embolisation and measurement of pulmonary artery pressure.

CT: computed tomography
HHT: hereditary haemorrhagic telangiectasia
PAVMs: pulmonary arterial malformations

Characteristics of ongoing studies [ordered by study ID]

Ir a:

NCT01856842

Trial name or title

Reperfusion of Pulmonary Arteriovenous Malformations After Embolotherapy. A Randomized Trial of Interlock™ Fibered IDC™ Occlusion System vs. Nester Coils

Methods

Single‐centre randomised controlled trial in Toronto, Canada.

Single blind (participant)

Participants

Inclusion criteria:

‐ documented presence of new (untreated) pulmonary AVMs requiring embolization;

‐ definite clinical diagnosis of HHT or genetic diagnosis of HHT;

‐ age ≥18 years;

‐ able to provide informed consent;

Exclusion criteria:

‐ participants with multiple AVMs within close proximity where identification of the aneurysm seen on CT cannot be precisely isolated for randomization purposes;

‐ contra‐indications to embolotherapy including severe chronic renal failure, without availability of dialysis. Severe pulmonary hypertension (PA systolic estimated at >60mmHg)

Interventions

This study will compare the success rate of embolization between the Interlock™ Fibered IDC™ Occlusion System (IDC coil) and the Nester coil.

Outcomes

Primary outcome measure

‐ difference in reperfusion rate between the 2 treatment groups from procedure day to the final follow‐up at 10‐14 month post embolization, measured by the unenhanced CT chest

Secondary outcome measures

‐ fluoroscopy/radiation time

‐ contrast volume required
‐ procedural time
‐ complication rates
‐ cost analysis

Starting date

March 2014 ‐ currently recruiting participants

Contact information

Vikram Prabhudesai, MD. [email protected]

Notes

https://clinicaltrials.gov/ct2/show/NCT01856842?term=pulmonary+arteriovenous+malformation&rank=1

AVMs: arterial malformations
CT: computer tomography
HHT: hereditary haemorrhagic telangiectasia